GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Compugen Ltd (NAS:CGEN) » Definitions » Other Gross PPE

CGEN (Compugen) Other Gross PPE : $5.16 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Compugen Other Gross PPE?

Compugen's Other Gross PPE for the quarter that ended in Dec. 2024 was $5.16 Mil.

Compugen's quarterly Other Gross PPE declined from Jun. 2024 ($4.09 Mil) to Sep. 2024 ($3.90 Mil) but then increased from Sep. 2024 ($3.90 Mil) to Dec. 2024 ($5.16 Mil).

Compugen's annual Other Gross PPE declined from Dec. 2022 ($4.14 Mil) to Dec. 2023 ($3.64 Mil) but then increased from Dec. 2023 ($3.64 Mil) to Dec. 2024 ($5.16 Mil).


Compugen Other Gross PPE Historical Data

The historical data trend for Compugen's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compugen Other Gross PPE Chart

Compugen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.09 4.57 4.14 3.64 5.16

Compugen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 4.20 4.09 3.90 5.16

Compugen Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Compugen Business Description

Traded in Other Exchanges
Address
26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.